Marksans Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Marksans Pharma has a total shareholder equity of ₹19.0B and total debt of ₹1.1B, which brings its debt-to-equity ratio to 5.9%. Its total assets and total liabilities are ₹23.1B and ₹4.2B respectively. Marksans Pharma's EBIT is ₹3.9B making its interest coverage ratio -62.5. It has cash and short-term investments of ₹6.6B.
Key information
5.9%
Debt to equity ratio
₹1.11b
Debt
Interest coverage ratio | -62.5x |
Cash | ₹6.61b |
Equity | ₹18.97b |
Total liabilities | ₹4.17b |
Total assets | ₹23.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524404's short term assets (₹17.0B) exceed its short term liabilities (₹3.3B).
Long Term Liabilities: 524404's short term assets (₹17.0B) exceed its long term liabilities (₹838.2M).
Debt to Equity History and Analysis
Debt Level: 524404 has more cash than its total debt.
Reducing Debt: 524404's debt to equity ratio has reduced from 21.3% to 5.9% over the past 5 years.
Debt Coverage: 524404's debt is well covered by operating cash flow (227.6%).
Interest Coverage: 524404 earns more interest than it pays, so coverage of interest payments is not a concern.